fbpx

221AD304 Phase 3b Study of Aducanumab (BIIB037) in Early Alzheimer’s Disease.  This trial is being conducted by the Australian Alzheimer’s Research Foundation.  Affinity Research is providing nursing support for this study. For more information, please click here or phone (08) 9389 6433 or Email: aarfctd@alzheimers.com.au.